166 related articles for article (PubMed ID: 18373208)
21. Hydrazone, benzohydrazones and isoniazid-acylhydrazones as potential antituberculosis agents.
Sampiron EG; Costacurta GF; Baldin VP; Almeida AL; Ieque AL; Santos NC; Alves-Olher VG; Vandresen F; Gimenes AC; Siqueira VL; Caleffi-Ferracioli KR; Cardoso RF; Scodro RB
Future Microbiol; 2019 Jul; 14():981-994. PubMed ID: 31382801
[No Abstract] [Full Text] [Related]
22. Developing an antituberculosis compounds database and data mining in the search of a motif responsible for the activity of a diverse class of antituberculosis agents.
Prakash O; Ghosh I
J Chem Inf Model; 2006; 46(1):17-23. PubMed ID: 16426035
[TBL] [Abstract][Full Text] [Related]
23. QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.
Gomes MN; Braga RC; Grzelak EM; Neves BJ; Muratov E; Ma R; Klein LL; Cho S; Oliveira GR; Franzblau SG; Andrade CH
Eur J Med Chem; 2017 Sep; 137():126-138. PubMed ID: 28582669
[TBL] [Abstract][Full Text] [Related]
24. ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines.
Saxena AK; Alam M
Curr Top Med Chem; 2020; 20(29):2723-2734. PubMed ID: 32885753
[TBL] [Abstract][Full Text] [Related]
25. DFT based QSAR/QSPR models in the development of novel anti-tuberculosis drugs targeting Mycobacterium tuberculosis.
Rajkhowa S; Deka RC
Curr Pharm Des; 2014; 20(27):4455-73. PubMed ID: 24245759
[TBL] [Abstract][Full Text] [Related]
26. Cinnamic Derivatives as Antitubercular Agents: Characterization by Quantitative Structure-Activity Relationship Studies.
Teixeira C; Ventura C; Gomes JRB; Gomes P; Martins F
Molecules; 2020 Jan; 25(3):. PubMed ID: 31973244
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, in vitro antitubercular activity and 3D-QSAR study of 1,4-dihydropyridines.
Manvar AT; Pissurlenkar RR; Virsodia VR; Upadhyay KD; Manvar DR; Mishra AK; Acharya HD; Parecha AR; Dholakia CD; Shah AK; Coutinho EC
Mol Divers; 2010 May; 14(2):285-305. PubMed ID: 19554465
[TBL] [Abstract][Full Text] [Related]
28. Pharmacophore assessment through 3-D QSAR: evaluation of the predictive ability on new derivatives by the application on a series of antitubercular agents.
Friggeri L; Ballante F; Ragno R; Musmuca I; De Vita D; Manetti F; Biava M; Scipione L; Di Santo R; Costi R; Feroci M; Tortorella S
J Chem Inf Model; 2013 Jun; 53(6):1463-74. PubMed ID: 23617317
[TBL] [Abstract][Full Text] [Related]
29. A Structure-Activity Relationship Study of Naphthoquinone Derivatives as Antitubercular Agents Using Molecular Modeling Techniques.
Sharma MC
Interdiscip Sci; 2015 Dec; 7(4):346-56. PubMed ID: 26159131
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Biological Evaluation of Hybrid 1,5- and 2,5-Disubstituted Indoles as Potentially New Antitubercular Agents.
Soares A; Estevao MS; Marques MMB; Kovalishyn V; Latino DARS; Aires-de-Sousa J; Ramos J; Viveiros M; Martins F
Med Chem; 2017; 13(5):439-447. PubMed ID: 28185538
[TBL] [Abstract][Full Text] [Related]
31. Four hydrazide compounds that inhibit the growth of mycobacterium tuberculosis.
Bartzatt R; Cirillo SL; Cirillo JD
Physiol Chem Phys Med NMR; 2008; 40():55-65. PubMed ID: 20070040
[TBL] [Abstract][Full Text] [Related]
32. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
Salum Lde B; Polikarpov I; Andricopulo AD
J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
[TBL] [Abstract][Full Text] [Related]
33. Development of isoniazid-NAD truncated adducts embedding a lipophilic fragment as potential bi-substrate InhA inhibitors and antimycobacterial agents.
Delaine T; Bernardes-Génisson V; Quémard A; Constant P; Meunier B; Bernadou J
Eur J Med Chem; 2010 Oct; 45(10):4554-61. PubMed ID: 20696503
[TBL] [Abstract][Full Text] [Related]
34. QSAR, docking studies of 1,3-thiazinan-3-yl isonicotinamide derivatives for antitubercular activity.
Chitre TS; Asgaonkar KD; Patil SM; Kumar S; Khedkar VM; Garud DR
Comput Biol Chem; 2017 Jun; 68():211-218. PubMed ID: 28411471
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, in vitro antitubercular activity and 3D-QSAR of novel quinoxaline derivatives.
Puratchikody A; Natarajan R; Jayapal M; Doble M
Chem Biol Drug Des; 2011 Dec; 78(6):988-98. PubMed ID: 21951363
[TBL] [Abstract][Full Text] [Related]
36. Isoniazid-phytochemical conjugation: A new approach for potent and less toxic anti-TB drug development.
Swain SS; Paidesetty SK; Padhy RN; Hussain T
Chem Biol Drug Des; 2020 Aug; 96(2):714-730. PubMed ID: 32237023
[TBL] [Abstract][Full Text] [Related]
37. Hybrid Design of Isonicotinic Acid Hydrazide Derivatives: Machine Learning Studies, Synthesis and Biological Evaluation of their Antituberculosis Activity.
Kovalishyn V; Hodyna D; Sinenko VO; Blagodatny V; Semenyuta I; Slivchuk SR; Brovarets V; Poda G; Metelytsia L
Curr Drug Discov Technol; 2020; 17(3):365-375. PubMed ID: 30973110
[TBL] [Abstract][Full Text] [Related]
38. Quantitative structure activity relationship (QSAR) modeling study of some novel thiazolidine 4-one derivatives as potent anti-tubercular agents.
Moulishankar A; Thirugnanasambandam S
J Recept Signal Transduct Res; 2023 Jun; 43(3):83-92. PubMed ID: 37990804
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships on purine and 2,3-dihydropurine derivatives as antitubercular agents: a data mining approach.
Pietra D; Imbriani M; Borghini A; Giorgi I; Settimo FD; Breschi MC; Campa M; Batoni G; Brancatisano FL; Bianucci AM
Chem Biol Drug Des; 2011 Oct; 78(4):718-24. PubMed ID: 21756283
[TBL] [Abstract][Full Text] [Related]
40. Discovery of Indeno[1,2-c]quinoline Derivatives as Potent Dual Antituberculosis and Anti-Inflammatory Agents.
Tseng CH; Tung CW; Wu CH; Tzeng CC; Chen YH; Hwang TL; Chen YL
Molecules; 2017 Jun; 22(6):. PubMed ID: 28621733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]